Is money thicker than health? - Economic motivated off-label prescription in an austere Europe

AUTHORS

Vera Lúcia Raposo 1 , *

1 Faculty of Law, Coimbra University, Portugal & Faculty of Law, Macau University, China

How to Cite: Raposo V L . Is money thicker than health? - Economic motivated off-label prescription in an austere Europe, Int J Health Life Sci. 2017 ; 3(1):e74182.

ARTICLE INFORMATION

International Journal of Health and Life Sciences: 3 (1); e74182
Published Online: July 01, 2017
Article Type: Review Article
Received: June 02, 2017
Accepted: June 15, 2017

Crossmark

CHEKING

READ FULL TEXT
Abstract

Off-label prescription is common in Europe and economically motivated off-label prescription is being increasingly recognised by the national laws of the Member States of the European Union, even though both European law and the European courts refute the prevalence of financial considerations over public health.

This article examines the causes of economically motivated off-label prescription, the current legislative and administrative measures implemented in several European countries and its consequences, and it concludes that in very specific scenarios off-label prescription grounded in economic reasons should be allowed.

Keywords

Legislation & jurisprudence Legislation Drug

© 2017, International Journal of Health and Life Sciences. This is an open-access article distributed under the terms of the Creative Commons Attribution-NonCommercial 4.0 International License (http://creativecommons.org/licenses/by-nc/4.0/) which permits copy and redistribute the material just in noncommercial usages, provided the original work is properly cited.

Fulltext

The full text of this article is available on PDF.

References

  • 1.

    The references of this article is available on PDF.

  • COMMENTS

    LEAVE A COMMENT HERE: